✦ LIBER ✦

Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms

✍ Scribed by Pierre J Blanchet; Frédéric Calon; Marc Morissette; Abdallah Hadj Tahar; Nancy Bélanger; Pershia Samadi; Richard Grondin; Laurent Grégoire; Leonard Meltzer; Thérèse Di Paolo; Paul J Bédard

Book ID: 116819961
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 244 KB
Volume: 10
Category: Article
ISSN: 1353-8020
DOI: 10.1016/j.parkreldis.2004.02.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

L-dopa dose and the duration and severit

L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates

✍ M. Kuoppamäki; G. Al-Barghouthy; M. J. Jackson; L. A. Smith; N. Quinn; P. Jenner 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 248 KB

Relationship among nigrostriatal denerva

Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model

✍ Donato A. Di Monte; Alison McCormack; Giselle Petzinger; Ann Marie Janson; Maryk 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Stimulation of cannabinoid receptors red

Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease

✍ Susan H. Fox; Brian Henry; Michael Hill; Alan Crossman; Jonathan Brotchie 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB 👁 1 views

Long-term treatment with levodopa in Parkinson's disease results in the development of motor fluctuations, including reduced duration of antiparkinsonian action and involuntary movements, i.e., levodopa-induced dyskinesia. Cannabinoid receptors are concentrated in the basal ganglia, and stimulation

Alterations of striatal NMDA receptor su

Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease

✍ P.J. Hallett; A.W. Dunah; P. Ravenscroft; S. Zhou; E. Bezard; A.R. Crossman; J.M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 458 KB

μ- and δ-Opioid Receptor Antagonists Red

μ- and δ-Opioid Receptor Antagonists Reduce Levodopa-Induced Dyskinesia in the MPTP-Lesioned Primate Model of Parkinson's Disease

✍ Brian Henry; Susan H. Fox; Alan R. Crossman; Jonathan M. Brotchie 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Reliability and validity of a new global

Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate

✍ G.M. Petzinger; M. Quik; E. Ivashina; M.W. Jakowec; M. Jakubiak; D. Di Monte; J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB

## Abstract Behavioral rating scales for dyskinesia in the non‐human primate are frequently used to assess the efficacy of new treatments and to provide a clinical correlative with neurochemical and neuropathological changes. Although a large variety of different scales have been used in non‐human